{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:52:24Z","timestamp":1773809544051,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005501","name":"BIRD","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005501","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Cardiac, Thoracic, Vascular and Public Health sciences, University of Padova, Italy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.phrs.2019.04.027","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T21:06:44Z","timestamp":1556140004000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anti-arrhythmic therapy in athletes"],"prefix":"10.1016","volume":"144","author":[{"given":"Alessandro","family":"Zorzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.04.027_bib0005","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jcmg.2018.04.031","article-title":"Diagnostic differentiation between arrhythmogenic cardiomyopathy and athlete\u2019s heart by using imaging","volume":"11","author":"D\u2019Ascenzi","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.phrs.2019.04.027_bib0010","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1161\/CIR.0000000000000245","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American heart association and American college of cardiology","volume":"132","author":"Zipes","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.04.027_bib0015","article-title":"Review of WADA prohibited substances: limited evidence for performance-enhancing effects","author":"Heuberger","year":"2018","journal-title":"Sports Med."},{"key":"10.1016\/j.phrs.2019.04.027_bib0020","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.hlc.2017.05.116","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy","volume":"26","author":"Vaidya","year":"2017","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.phrs.2019.04.027_bib0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/jce.13245","article-title":"Application of the 2015 ACC\/AHA\/HRS guidelines for risk stratification for sudden death in adult patients with asymptomatic pre-excitation","volume":"28","author":"Obeyesekere","year":"2017","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0030","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.hrthm.2016.06.008","article-title":"Atrial fibrillation in inherited cardiac channelopathies: from mechanisms to management","volume":"13","author":"Enriquez","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.phrs.2019.04.027_bib0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11936-017-0583-x","article-title":"Management of arrhythmias in athletes: atrial fibrillation, premature ventricular contractions, and ventricular tachycardia","volume":"19","author":"Lai","year":"2017","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2019.04.027_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/sms.12679","article-title":"The prevalence and clinical significance of premature ventricular beats in the athlete","volume":"27","author":"D\u2019Ascenzi","year":"2017","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.phrs.2019.04.027_bib0045","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/eurheartj\/ehi325","volume":"26","author":"Pelliccia","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2019.04.027_bib0050","first-page":"1309","article-title":"Atrial fibrillation in athletes: pathophysiology, clinical presentation, evaluation and management","volume":"8","author":"Turagam","year":"2015","journal-title":"J. Atr. Fibrillation"},{"key":"10.1016\/j.phrs.2019.04.027_bib0055","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1177\/2047487313476414","article-title":"Atrial fibrillation in endurance athletes","volume":"21","author":"Wilhelm","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0060","first-page":"S63","article-title":"Atrial fibrillation in elite athletes","volume":"9","author":"Furlanello","year":"1998","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.eupc.2004.01.004","article-title":"Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up","volume":"6","author":"Hoogsteen","year":"2004","journal-title":"Europace"},{"key":"10.1016\/j.phrs.2019.04.027_bib0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0735-1097(02)01977-0","article-title":"Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes","volume":"40","author":"Biffi","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0075","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1177\/2047487318797396","article-title":"Burden of ventricular arrhythmias at 12-lead 24-hour ambulatory ECG monitoring in middle-aged endurance athletes versus sedentary controls","volume":"25","author":"Zorzi","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0080","first-page":"7","article-title":"Ventricular arrhythmias in young competitive athletes: prevalence, determinants, and underlying substrate","author":"Zorzi","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2019.04.027_bib0085","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2004.05.065","article-title":"Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes","volume":"44","author":"Biffi","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0090","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.amjcard.2013.06.032","article-title":"Long-term effect of continuing sports activity in competitive athletes with frequent ventricular premature complexes and apparently normal heart","volume":"112","author":"Delise","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1755-5922.2011.00306.x","article-title":"Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity","volume":"31","author":"Ladage","year":"2013","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2019.04.027_bib0100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0002-9149(90)90486-K","article-title":"Cardiac and skeletal muscle adaptations to training in systemic hypertension and effect of beta blockade (metoprolol or propranolol)","volume":"66","author":"Ades","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00007256-198805040-00002","article-title":"Beta-adrenoceptor blockade and exercise. An update","volume":"5","author":"Van Baak","year":"1988","journal-title":"Sports Med."},{"key":"10.1016\/j.phrs.2019.04.027_bib0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2125.1988.tb03288.x","article-title":"Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects","volume":"25","author":"van Baak","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0115","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1249\/MSS.0b013e31817fbe11","article-title":"Beta-adrenergic blockade and metabo-chemoreflex contributions to exercise capacity","volume":"40","author":"Beloka","year":"2008","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.phrs.2019.04.027_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004872-200018010-00006","article-title":"Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men","volume":"18","author":"Vanhees","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2019.04.027_bib0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00051145","article-title":"Exercise tolerance with nebivolol and atenolol","volume":"6","author":"Van Bortel","year":"1992","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.phrs.2019.04.027_bib0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00007256-198704030-00003","article-title":"Calcium antagonists and exercise performance","volume":"4","author":"Kindermann","year":"1987","journal-title":"Sports Med."},{"issue":"37","key":"10.1016\/j.phrs.2019.04.027_bib0135","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"2016","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2019.04.027_bib0140","first-page":"242","article-title":"Atrial fibrillation and the pharmacological treatment: the role of propafenone","volume":"16","author":"Sestito","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2019.04.027_bib0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v7.i2.76","article-title":"Flecainide: current status and perspectives in arrhythmia management","volume":"7","author":"Andrikopoulos","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1113\/jphysiol.2004.065003","article-title":"State-dependent trapping of flecainide in the cardiac sodium channel","volume":"560","author":"Ramos","year":"2004","journal-title":"J Physiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1067\/mcp.2002.125946","article-title":"Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism","volume":"72","author":"Tenneze","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2019.04.027_bib0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/europace\/euv195","article-title":"Propafenone shows class Ic and class II antiarrhythmic effects","volume":"18","author":"Stoschitzky","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.phrs.2019.04.027_bib0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11599950-000000000-00000","article-title":"Safety of flecainide","volume":"35","author":"Tamargo","year":"2012","journal-title":"Drug Saf."},{"key":"10.1016\/j.phrs.2019.04.027_bib0170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/clc.4960180307","article-title":"Effects of flecainide on exercise hemodynamics and electrocardiography in patients without structural heart disease","volume":"18","author":"Wang","year":"1995","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0175","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12012-016-9380-0","article-title":"Flecainide toxicity: a case report and systematic review of its electrocardiographic patterns and management","volume":"17","author":"Valentino","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0180","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/europace\/euv462","article-title":"Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation","volume":"18","author":"Capucci","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.phrs.2019.04.027_bib0185","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.amjcard.2015.05.039","article-title":"Utility of routine exercise testing to detect rate-related QRS widening in patients without structural heart disease on class Ic antiarrhythmic agents (Flecainide and Propafenone)","volume":"116","author":"Vallurupalli","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ccep.2016.02.007","volume":"8","author":"Kpaeyeh","year":"2016","journal-title":"Sotalol. Card Electrophysiol. Clin."},{"key":"10.1016\/j.phrs.2019.04.027_bib0195","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijcard.2011.06.012","article-title":"Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits","volume":"155","author":"Camm","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0200","doi-asserted-by":"crossref","first-page":"44A","DOI":"10.1016\/0002-9149(93)90024-7","article-title":"Clinical safety profile of sotalol in the treatment of arrhythmias","volume":"72","author":"MacNeil","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0205","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1161\/01.CIR.94.10.2535","article-title":"Sex difference in risk of torsade de pointes with d,l-sotalol","volume":"94","author":"Lehmann","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.04.027_bib0210","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.100.19.2025","article-title":"Evidence-based analysis of amiodarone efficacy and safety","volume":"100","author":"Connolly","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2019.04.027_bib0215","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/clc.4960200706","article-title":"Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy","volume":"20","author":"Singh","year":"1997","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0220","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjmed.2015.08.039","article-title":"Practical management guide for clinicians who treat patients with amiodarone","volume":"129","author":"Epstein","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2019.04.027_bib0225","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.bjp.0704106","article-title":"Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone","volume":"133","author":"Varro","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03091794","article-title":"Dronedarone in patients with atrial fibrillation","volume":"18","author":"de Groot","year":"2010","journal-title":"Neth. Heart J."},{"key":"10.1016\/j.phrs.2019.04.027_bib0235","first-page":"27","article-title":"Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation","volume":"5","author":"Schweizer","year":"2011","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phrs.2019.04.027_bib0240","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1080\/14740338.2017.1387246","article-title":"Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation","volume":"16","author":"Khan","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.phrs.2019.04.027_bib0245","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1540-8159.2012.03372.x","article-title":"Radiofrequency and cryoablation therapies for supraventricular arrhythmias in the young: five-year review of efficacies","volume":"35","author":"Buddhe","year":"2012","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ccep.2016.04.004","article-title":"Outflow tract premature ventricular contractions and ventricular tachycardia: the typical and the challenging","volume":"8","author":"John","year":"2016","journal-title":"Card. Electrophysiol. Clin."},{"issue":"13","key":"10.1016\/j.phrs.2019.04.027_bib0255","first-page":"e136","article-title":"ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"2016","author":"Page","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.phrs.2019.04.027_bib0260","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0002-9149(84)80162-9","article-title":"Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil","volume":"54","author":"Winniford","year":"1984","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0265","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/hrt.48.2.140","article-title":"Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man","volume":"48","author":"Hellestrand","year":"1982","journal-title":"Br. Heart J."},{"issue":"18","key":"10.1016\/j.phrs.2019.04.027_bib0270","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"2016","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.phrs.2019.04.027_bib0275","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \"pill-in-the-pocket\" approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2019.04.027_bib0280","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0002-9149(99)00275-1","article-title":"Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and\/or atrial flutter. d,l-Sotalol Atrial Fibrillation\/Flutter Study Group","volume":"84","author":"Benditt","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0285","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/eurheartj\/ehu291","article-title":"Catheter ablation of atrial fibrillation: an update","volume":"35","author":"Haegeli","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2019.04.027_bib0290","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1540-8167.2007.01077.x","article-title":"Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition","volume":"19","author":"Furlanello","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/europace\/eup320","article-title":"Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes","volume":"12","author":"Calvo","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.phrs.2019.04.027_bib0300","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/europace\/eur142","article-title":"Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation","volume":"13","author":"Koopman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.phrs.2019.04.027_bib0305","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jacep.2017.07.002","article-title":"Risk of catheter ablation for atrial fibrillation","volume":"3","author":"Corrado","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0310","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0195-668X(02)00846-1","article-title":"Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation","volume":"24","author":"Schmieder","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2019.04.027_bib0315","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14779072.2016.1221342","article-title":"Medical therapy to prevent recurrence of ventricular arrhythmia in normal and structural heart disease patients","volume":"14","author":"Jacobson","year":"2016","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2019.04.027_bib0320","first-page":"5","article-title":"Consumption of caffeinated products and cardiac ectopy","author":"Dixit","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2019.04.027_bib0325","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/hrt.76.4.355","article-title":"Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats","volume":"76","author":"Newby","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2019.04.027_bib0330","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/hrt.68.10.392","article-title":"Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality","volume":"68","author":"Gill","year":"1992","journal-title":"Br. Heart J."},{"key":"10.1016\/j.phrs.2019.04.027_bib0335","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.hrthm.2013.10.033","article-title":"Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study","volume":"11","author":"Zhong","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.phrs.2019.04.027_bib0340","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jelectrocard.2018.06.007","article-title":"New insights on verapamil-sensitive idiopathic left fascicular tachycardia","volume":"51","author":"Michowitz","year":"2018","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.phrs.2019.04.027_bib0345","series-title":"Protocolli cardiologici per il giudizio di idoneit\u00e0 allo sport agonistico","author":"Comitato organizzativo cardiologico idoneit\u00e0 allo sport (COCIS)","year":"2017"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819301483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819301483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:01:34Z","timestamp":1760911294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819301483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":69,"alternative-id":["S1043661819301483"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.027","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-arrhythmic therapy in athletes","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}